Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics #00448

Submission Number:
00448
Commenter:
Nobis
State:
Georgia
Initiative Name:
Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics
1am a pharmacy owner and what is going on is beyond my imagination. The reimbursement is below cost which means my beloved customers are not served.PMBS tell customers not to go to particular pharmacy but the pharmacist are to told not direct a customer to particular network. Also customer are directed to use mail order against their wishes. PLEASE FTC BLOCK CVS FROM BUYING ATENA BECAUSE THAT WILL BE THE END OF INDEPENDENT/COMMUNITY PHARMACY AND STOP CLAW BACKS.